Product Images Liraglutide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 35 images provide visual information about the product associated with Liraglutide NDC 0480-3667 by Teva Pharmaceuticals Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton_2_pens - carton 2 pens

This text provides detailed information about Liraglutide injection, which is administered subcutaneously under the direction of a healthcare professional. It contains 18 mg/3 mL (6 mg/mL) of liraglutide as the active ingredient, along with various inactive ingredients. The medication is available in a prefilled pen, which can deliver different doses. It should be refrigerated and not frozen. The product is not child-resistant, and if the seal is broken, the pharmacist should be contacted. The manufacturer is Teva Pharmaceuticals in the US and Novo Nordisk in Denmark. Each pen is for single-patient use only and should be discarded after 30 days. Additional details include product literature, disposal instructions, and relevant identification codes.*

carton_3_pens - carton 3 pens

This text describes a medication called Liraglutide injection, which is provided in prefilled pens containing 18 mg/3 mL (6 mg/mL). It is for subcutaneous use only and each pen is intended for single-patient use. The medication contains liraglutide 6mg per mL along with inactive ingredients. It is important to refrigerate the pens and not freeze them. After the first use, they should be stored at a temperature not exceeding 86°F (30°C). The product should not be transferred to a syringe, and each pen can deliver multiple doses of 0.6 mg, 1.2 mg, or 1.8 mg. Additionally, it mentions details for contacting Teva Pharmaceuticals and Novo Nordisk A/S for manufacturing information.*

figure-1 - figure 1

figure-2 - figure 2

This is a graph showing the comparison of ISR (pmol/kg/min), Liraglutide, and Placebo based on plasma glucose levels (mg/dL). The x-axis represents plasma glucose levels ranging from 80 to 220 mg/dL, while the y-axis indicates ISR values in pmol/kg/min. The data points show how ISR changes in response to Liraglutide and Placebo across different plasma glucose concentrations.*

figure_3 - figure 3

This text appears to be a numerical data showing doses of Glimepiride, Liraglutide 1.2 mg, and Liraglutide 1.8 mg over a period of time (weeks). The graph probably depicts the medication dosage changes and their effects over time.*

figure_4 - figure 4

This text appears to be outlining measurements of Mean HbA (%) over time, with data points for different medications or dosages such as Liraglutide 1.2 mg, Liraglutide 1.8 mg, and Sitagliptin 100 mg. The measurements are taken at various time points ranging from 0 to 26 weeks. This data is likely part of a study or analysis related to managing or monitoring HbA levels in patients. It provides a visual representation of how these medications may impact Mean HbA (%) levels over time.*

figure-5 - figure 5

pen_image - image 01

injection-pen - image 22

Description not available.*

needle-example - image 23

A description of a needle with outer and inner parts, including protective cap and needle tab for safety.*

triangle_1 - image 24

triangle_2 - image 25

triangle_3 - image 26

tirangle_4 - image 27

triangle_5 - image 28

triangle_6 - image 29

tirangle_7 - image 30

triangle_8 - image 31

image-a - image 32

image-b - image 33

image-c - image 34

image-d - image 35

image-e - image 36

image-f - image 37

image-g - image 38

image-h - image 39

image-i - image 40

image-j - image 41

image-k - image 42

image-l - image 43

image-m - image 44

image-n - image 45

image-o - image 46

image-p - image 47

image-q - image 48

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents